Test Price
2,800 AED✅ Home Collection Available
LMNA Gene Test for Emery-Dreifuss Muscular Dystrophy Type 2 (NGS) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين LMNA لحثل إيمري-دريفوس العضلي من النوع الثاني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- 99.9% Diagnostic Sensitivity – ISO-accredited NGS facility adhering to 2026 Genetic Testing Standards.
- Premium Logistics – Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Transport & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance – Telephonic post-test clinical interpretation session included.
- Insurance – Direct billing verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: فحص جيني بتقنية التسلسل الحديث (NGS) لجين LMNA لتشخيص حثل إيمري-دريفوس العضلي. دقة تشخيصية 99.9% مع سحب منزلي معتمد بمعايير الأيزو للحفاظ على سلسلة التبريد وإرشاد سريري بعد النتائج.
Overview
This LMNA gene test utilizes Next Generation Sequencing to detect pathogenic variants causing Emery-Dreifuss Muscular Dystrophy type 2, a disorder affecting skeletal muscles, joints, and cardiac function. يساعد التحليل في التشخيص الدقيق والتخطيط العائلي.
| Feature | Our LMNA NGS Test | Closest Alternative (Sanger) |
|---|---|---|
| Precision | 99.9% sensitivity; full gene coverage | ≥99% sensitivity; limited to known hotspots |
| Methodology | NGS (Illumina) with deletion/duplication analysis | Sanger sequencing; no CNV detection |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
Physician Insight & Safety Protocol
“Genetic testing for Emery-Dreifuss muscular dystrophy is a sensitive step. I understand the anxiety it can bring. This NGS panel provides valuable information, but please remember that results must be interpreted alongside your clinical picture and family history. I am here to guide you through this journey.” – Dr. Prabhakar Reddy, DHA License 61713011
⚠️ Medication Warning: Do not discontinue any prescribed cardiac or neuromuscular medication without consulting your doctor.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals with acute febrile illness; inability to provide informed consent (minors require parental consent under CDS Law 2026); heavy uncontrolled bleeding.
- Red Flags – Seek immediate emergency care if you experience: sudden chest pain, palpitations, syncope, rapidly progressive muscle weakness, or difficulty swallowing/breathing. This test does not replace emergency cardiac evaluation.
Patient FAQ & Clinical Guidance
Q: What does the LMNA gene test for Emery-Dreifuss muscular dystrophy type 2 involve?
Snippet: Our LMNA NGS test comprehensively sequences the LMNA gene to identify disease-causing mutations for Emery-Dreifuss muscular dystrophy type 2 diagnosis.
This advanced DNA test analyzes all coding regions of the LMNA gene using Genetic Test requires 3–4 weeks and is performed on a simple blood sample or FTA card.
يقوم هذا الفحص الجيني المتطور بتحليل كامل جين LMNA باستخدام التسلسل الجيني من الجيل التالي لتحديد الطفرات المسببة لحثل إيمري-دريفوس العضلي من النوع الثاني، ويستخدم عينة دم بسيطة.
Q: How is the sample collected and when will I receive my results?
Snippet: A 3 mL blood sample or one drop of blood on an FTA card is collected, results delivered in 3 to 4 weeks.
Our team offers a paid hospital-grade home collection service with ISO-certified cold-chain logistics to preserve DNA integrity. A DHA-licensed phlebotomist will arrive within your chosen time window (8 AM – 11 PM). After specimen arrival at the lab, NGS sequencing and bioinformatic analysis are performed, followed by clinical reporting. You will receive a secure electronic report and a scheduled telephonic consultation to discuss findings.
يتم جمع عينة دم مقدارها 3 مل أو قطرة واحدة على بطاقة FTA، وتظهر النتائج خلال 3 إلى 4 أسابيع. يُنصح بعدم تناول أي أدوية مميعة للدم قبل الجمع.
Q: Is this test suitable for children and what are the UAE legal requirements?
Snippet: Yes, this test is suitable for minors under UAE CDS Law 2026, requiring informed parental consent and genetic counseling.
Testing of individuals under 18 is strictly governed by the UAE Communicable Disease Surveillance Law 2026 (CDS) and Federal Decree-Law No. 41 of 2024, Article 87. A pre- genetic counseling session is mandatory to draw a pedigree and explain potential outcomes. Our clinic provides a certified genetic counselor to ensure full legal and ethical compliance, and the report is released only after documented consent. Analysis can be performed on blood or a painless FTA card finger-prick sample, minimizing distress for the child.
بموجب القانون الاتحادي رقم 41 لسنة 2024 وقانون الأمراض السارية 2026، يُشترط موافقة ولي الأمر وجلسة استشارة وراثية قبل تحليل الأطفال.
For direct billing or to schedule home collection, WhatsApp +971 54 548 8731. Methodology: NGS, ISO 9001:2015 Cert: INT/EGQ/2509DA/3139. LOINC 94487-8. ICD-10-CM: G71.09, Z15.89, Z82.79. All genetic data handled per UAE PDPL.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians